Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Cells|March 6, 2019
Mycoplasma genitalium Infection and Chronic Inflammation in Human Prostate Cancer: Detection Using Prostatectomy and Needle Biopsy SpecimensMakito Miyake, Kenta Ohnishi, Shunta Hori, et al.
Oncology Letters|September 21, 2020
Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcomaMakito Miyake, Yuki Oda, Nobutaka Nishimura, et al.
Methods and Protocols|August 28, 2024
A Multicenter, Single-Arm, Prospective Trial to Evaluate Efficacy and Safety of Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Carboplatin (DD-MVACarbo) Chemotherapy for Cisplatin-Ineligible Patients with Advanced Urothelial Cancer: Study Protocol of the CARBUNCLE TrialMakito Miyake, Satoshi Anai, Yusuke Iemura, et al.
Oncotarget|April 19, 2017
Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladderMakito Miyake, Shunta Hori, Yosuke Morizawa, et al.
Cancer Management and Research|February 25, 2022
Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World DataMakito Miyake, Nobutaka Nishimura, Takuto Shimizu, et al.
Clinical Genitourinary Cancer|April 2, 2025
Impact of Initial Relative Dose Intensity on Tumor Response and Survival Outcomes in Enfortumab Vedotin Monotherapy for Previously Treated Advanced Urothelial Carcinoma: A Real-world Analysis From a Multicenter StudyMakito Miyake, Nobutaka Nishimura, Yusuke Iemura, et al.
Clinical Genitourinary Cancer|December 17, 2021
Response to Pembrolizumab After Dose-Reduced Cisplatin Plus Gemcitabine Chemotherapy Is Inferior to That After Carboplatin Plus Gemcitabine Chemotherapy in Cisplatin-Unfit Patients With Advanced Urothelial CarcinomaMakito Miyake, Takuto Shimizu, Nobutaka Nishimura, et al.
Cancer Chemotherapy and Pharmacology|June 25, 2025
Clinical relevance of Nectin-4 downregulation and biological changes caused by cytotoxic chemotherapy in bladder cancerMakito Miyake, Takuya Owari, Kota Iida, et al.
Scientific Reports|July 15, 2016
Urothelial ATP exocytosis: regulation of bladder compliance in the urine storage phaseHiroshi Nakagomi, Mitsuharu Yoshiyama, Tsutomu Mochizuki, et al.
Cancers|April 12, 2022
Organ-Specific and Mixed Responses to Pembrolizumab in Patients with Unresectable or Metastatic Urothelial Carcinoma: A Multicenter Retrospective StudyTakuto Shimizu, Makito Miyake, Nobutaka Nishimura, et al.
Pageof 18